Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
Journalists
Submit Release
January 24, 2009
 
Industry Categories  
News by Country  
News by MSA  
Today's News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Websites.
 
Close Move
All Press Releases for May 27, 2008 Subscribe to this News Feed    
 

Olympus Announces U.S. Release of Prolactin Assay For Olympus AU3000i® Immunoassay System

CENTER VALLEY, Pa. (Business Wire EON/PRWEB ) May 27, 2008 -- Olympus, a leader in the field of in vitro diagnostics, has introduced a prolactin assay for sale in the U.S. Measurement of prolactin is one of the most commonly undertaken hormonal investigations in evaluating patients with reproductive disorders. Prolactin levels are also determined when breast cancer and pituitary tumors are suspected. The assay is designed for use with the fully automated Olympus AU3000i® immunoassay system.

The prolactin assay is a two-step immunometric assay with a very broad measuring range of approximately 0.05 300 micrograms per liter (1.06 6360 mIU/L). It measures quantitative concentrations of prolactin in either 50 microliters of serum or lithium-heparin plasma samples after 28 minutes of processing time. Each prolactin kit is sufficient to process 100 tests, and contains prolactin reagents, a single ready-to-use calibrator, and a single ready-to-use control. Reagents are stable on board the AU3000i system for 28 days.

News Image The addition of the prolactin assay to the already available Olympus fertility assays LH and FSH is an important step in the development of a panel of tests comprising from seven to ten percent of the test volume in a routine clinical laboratory, said Lorraine Damico, Director of Immunoassay Marketing for Olympus America Inc.

For additional information about Olympus assays visit www.olympusamerica.com, or contact Lorraine Damico at 1-484-896-5463; or via email at lorraine.damico@olympus.com.

About this test

The Olympus prolactin assay is a paramagnetic particle (DynaBeads®) chemiluminescent immunoassay for the in vitro quantitative measurement of prolactin in human serum or lithium-heparin plasma. It is standardized against the 3rd WHO Ref Standard 84/500 for human prolactin. The main physiological function of this fertility hormone is to promote female breast development and to initiate and maintain lactation. Abnormally high levels of prolactin are associated with female infertility, impotence and infertility in men, primary hypothyroidism and pituitary tumors. Determination of prolactin concentrations can also be useful in the diagnosis and treatment of hypothalamic-pituitary disorders.

About Olympus Diagnostic Systems

Olympus Diagnostic Systems provides innovative solutions that meet the high productivity demands of hospitals, integrated healthcare delivery networks, reference labs, blood banks, physician offices and pharmaceutical labs. Olympus offers the broadest standardized line of random access chemistry-immuno analyzers, along with lab automation systems, blood bank analyzers and reagents. Olympus solutions save laboratories time, maximize productivity, and deliver fast, reliable results.

About Olympus

Olympus is a precision technology leader, creating innovative opto-digital solutions in healthcare, life science and consumer electronics products. Olympus works collaboratively with its customers and its affiliates worldwide to leverage R&D investment in precision technology and manufacturing processes across diverse business lines. These include:

· Gastrointestinal endoscopes, accessories, and minimally invasive surgical products;

· Advanced clinical and research microscopes;

· Lab automation systems, chemistry-immuno and blood bank analyzers and reagents;

· Digital cameras and voice recorders.

Olympus serves healthcare and commercial laboratory markets with integrated product solutions and financial, educational and consulting services that help customers to efficiently, reliably and more easily achieve exceptional results. Olympus develops breakthrough technologies with revolutionary product design and functionality for the consumer and professional photography markets, and also is the leader in gastrointestinal endoscopy and clinical and educational microscopes. For more information, visit www.olympusamerica.com.

All trademarks and registered trademarks are the property of their respective owners.

PHOTOGRAPH AVAILABLE

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/U3F1YS1JbnNlLVN1bW0tRmFsdS1DcmFzLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION

Edge Communications Inc.
R. Vincent Park, 914-684-0959
vincent@edge-comm.net

ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appearshere.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2009, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright